December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ultragenyx Pharmaceu (NQ: RARE )

139.65 USD +1.68 (+1.22%)
Streaming Delayed Price Updated: 10:04 AM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,391
Open 140.60
Bid (Size) 139.31 (1)
Ask (Size) 140.60 (1)
Prev. Close 137.97
Today's Range 138.10 - 141.94
52wk Range 31.99 - 179.65
Shares Outstanding 49,772,297
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Ultragenyx Reports Preliminary 2020 Revenue and 2021 Revenue Guidance for Crysvita in Ultragenyx Territories
From GlobeNewswire News Releases
Ultragenyx Announces Progress Across Broad Gene Therapy Portfolio and Positive Longer-Term Data from Multiple Phase 1/2 Gene Therapy Studies
From GlobeNewswire News Releases

Performance

YTD
+2.33%
+2.33%
1 Month
-16.58%
-16.58%
3 Month
+53.21%
+53.21%
6 Month
+58.86%
+58.86%
1 Year
+136.61%
+136.61%

More News

Read More
Ultragenyx to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference
From GlobeNewswire News Releases
28th Annual Emerald Groundhog Day Investment Forum Goes Virtual as Pandemic Casts a Long Shadow
From Business Wire News Releases
Ultragenyx and Mereo BioPharma Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta
From GlobeNewswire News Releases
Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta
From GlobeNewswire News Releases
Noteworthy ETF Outflows: IWO, RARE, DECK, CHDN
Tags ETFs
From ETF Channel
Noteworthy Friday Option Activity: RARE, NBIX, KRA
Tags Stocks
From Market News Video
The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks
Tags ALT FDA VTRS
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
Tags BLNK SIVB OSS
From Benzinga
The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
Tags VCEL ONCS PROF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.